GGrantIndex
Sort

261,768 grants matching gene therapy

Molecular Basis for γδ T Lineage Specification

$2,444,294
David L Wiest · Research Inst Of Fox Chase Can Ctr · P01 · FY2025 · AI

Model-based predictions of responses RTK Pathway therapies

$2,444,254
Joe W. Gray · Oregon Health & Science University · U54 · FY2014 · CA

SCOR in Neurobiology of Sleep and Sleep Apnea

$2,443,890
Allan Ian Pack · University Of Pennsylvania · P50 · FY2006 · HL

Hematopoiesis in cardiovascular disease

$2,443,825
Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2023 · HL

Hematopoiesis in cardiovascular disease

$2,443,825
Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2022 · HL

Cell and Molecular Pathobiology of Alzheimer's Disease

$2,443,714
Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2017 · AG

Targeted Therapies for Glioma

$2,442,975
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2025 · CA

RNA binding and packaging by retroviral Gag proteins

$2,442,836
Karin M Musier-Forsyth · Ohio State University · R01 · FY2025 · AI

A Gene therapeutic approach to stable suppression of HIV-1 replication

$2,442,349
Michael R. Farzan · Scripps Florida · P01 · FY2014 · AI

BET-BD1 Selective Neuroimaging probes for Alzheimer's disease research

$2,442,345
Changning Wang · Massachusetts General Hospital · RF1 · FY2023 · AG

Pathobiology of Neurodegeneration in C9ORF72 repeat expansion

$2,442,288
Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2020 · NS

Identifying causal gene programs for vascular disease using high throughput CRISPR genomics

$2,442,173
Thomas None Quertermous · Stanford University · P01 · FY2025 · HL

A Family-based Exome Sequencing Approach to Identify Platelet Aggregation Genes

$2,442,155
Rasika Ann Mathias · Johns Hopkins University · R01 · FY2015 · HL

Extending the Phenotype of Nonsyndromic Orofacial Clefting

$2,442,009
Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · DE

Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes

$2,441,919
Chad Albert Cowan · Massachusetts General Hospital · U01 · FY2014 · HL

Advancing Transplantation Outcomes in Children

$2,441,871
David Michael Briscoe · Boston Children'S Hospital · U01 · FY2022 · AI

Translational Research in Breast Cancer

$2,441,251
C Kent Osborne · Baylor College Of Medicine · P50 · FY2006 · CA

Polymerase theta, genome instability, and cancer

$2,440,899
Dale A Ramsden · Univ Of North Carolina Chapel Hill · P01 · FY2025 · CA

THE THERAPY OF AML

$2,440,745
Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA

Genes And Gene Products As Immunoadjuvants

$2,440,402
Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Genome-wide Search for CVD Gene-Environment Interactions

$2,440,104
University Of Maryland Baltimore · U01 · FY2005 · HL

Notch-Mediated Expansion of Cord Blood Progenitors for Stem Cell Transplant

$2,440,031
Colleen Delaney · Fred Hutchinson Cancer Research Center · P50 · FY2017 · HL

Cancer Center Support Grant (CCSG)

$2,440,011
George J Weiner · University Of Iowa · P30 · FY2016 · CA

Nanoscale approaches to allelic silencing in myocardial disease states

$2,439,872
Euan A Ashley · Stanford University · DP2 · FY2009 · OD

MEMORIAL SLOAN-KETTERING CANCER GENE THERAPY PROGRAM

$2,439,650
Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA